Systematic analysis of pyrazinamide-resistant spontaneous mutants and clinical isolates of Mycobacterium tuberculosis.
about
The Race Is On To Shorten the Turnaround Time for Diagnosis of Multidrug-Resistant TuberculosisSystematic review of mutations in pyrazinamidase associated with pyrazinamide resistance in Mycobacterium tuberculosis clinical isolatesA Global Perspective on Pyrazinamide Resistance: Systematic Review and Meta-AnalysisFrom multidrug- to extensively drug-resistant tuberculosis: upward trends as seen from a 15-year nationwide studyWhole genome sequencing reveals complex evolution patterns of multidrug-resistant Mycobacterium tuberculosis Beijing strains in patientsPyrazinamide resistance, Mycobacterium tuberculosis lineage and treatment outcomes in San Francisco, CaliforniaWhole genome sequencing based characterization of extensively drug-resistant Mycobacterium tuberculosis isolates from PakistanMDR-TB Outbreak among HIV-Negative Tunisian Patients followed during 11 YearsMechanisms of Pyrazinamide Action and ResistancePyrazinamide resistance-conferring mutations in pncA and the transmission of multidrug resistant TB in GeorgiaIn Vivo-Selected Pyrazinoic Acid-Resistant Mycobacterium tuberculosis Strains Harbor Missense Mutations in the Aspartate Decarboxylase PanD and the Unfoldase ClpC1.Phenotypic and genotypic characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates in Zhejiang, ChinaMutations in genes for the F420 biosynthetic pathway and a nitroreductase enzyme are the primary resistance determinants in spontaneous in vitro-selected PA-824-resistant mutants of Mycobacterium tuberculosisEpidemiologic Correlates of Pyrazinamide-Resistant Mycobacterium tuberculosis in New York City.Mycobacterium tuberculosis pncA Polymorphisms That Do Not Confer Pyrazinamide Resistance at a Breakpoint Concentration of 100 Micrograms per Milliliter in MGIT.Importance of the genetic diversity within the Mycobacterium tuberculosis complex for the development of novel antibiotics and diagnostic tests of drug resistanceContribution of moxifloxacin or levofloxacin in second-line regimens with or without continuation of pyrazinamide in murine tuberculosis.Resistance in tuberculosis: what do we know and where can we go?Mutation rate and the emergence of drug resistance in Mycobacterium tuberculosis.Pyrazinamide resistance in Mycobacterium tuberculosis fails to bite?Pyrazinamide Susceptibility and pncA Mutation Profiles of Mycobacterium tuberculosis among Multidrug-Resistant Tuberculosis Patients in Bangladesh.Evaluation of a novel line probe assay to detect resistance to pyrazinamide, a key drug used for tuberculosis treatment.Biochemical Characterization and Computational Identification of Mycobacterium tuberculosis Pyrazinamidase in Some Pyrazinamide-Resistant Isolates of Iran.Anti-tubercular Activity of Pyrazinamide is Independent of trans-Translation and RpsA.A comprehensive characterization of PncA polymorphisms that confer resistance to pyrazinamide.Pantothenate and pantetheine antagonize the antitubercular activity of pyrazinamideMolecular analysis of pyrazinamide resistance in Mycobacterium tuberculosis in Vietnam highlights the high rate of pyrazinamide resistance-associated mutations in clinical isolates.Genetic diversity within Mycobacterium tuberculosis complex impacts on the accuracy of genotypic pyrazinamide drug-susceptibility assay.Non-pncA Gene-Mutated but Pyrazinamide-Resistant Mycobacterium tuberculosis: Why Is That?Pyrazinamide Resistance Is Caused by Two Distinct Mechanisms: Prevention of Coenzyme A Depletion and Loss of Virulence Factor Synthesis.Is IQG-607 a Potential Metallodrug or Metallopro-Drug With a Defined Molecular Target in Mycobacterium tuberculosis?Insights into the processes that drive the evolution of drug resistance in Mycobacterium tuberculosisCharacterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis isolates from Korea and analysis of the correlation between the mutations and pyrazinamidase activity
P2860
Q26785997-3E027594-F97F-4630-8808-A331BF806379Q27004697-D1AEB735-F606-4FE6-AC31-C3B1939E50A5Q27011264-C660C541-BB0E-4B07-A76B-33A1AFDE7E33Q28487902-3218E320-6E9C-4D5E-A6DB-D038129EF7CBQ28536445-D5534867-D4D4-408F-80F6-C77A236E911AQ28538180-D5BD183C-1AE8-4F3C-830F-13CBF383146DQ28543682-B4E9C45A-7F35-4878-A870-82C9AE003D0AQ28551671-16A62FA9-9F2B-4BB1-89C8-85E86260A0A8Q29304444-90786B49-5961-4625-86BF-F397027B1662Q33896434-7BBD14E0-5011-40AF-960B-A87BBE79944CQ33912749-72767713-1C2A-45B2-AF8D-758D4613EAD1Q35076847-F0A615CE-1A59-4FF1-A817-427BF8AD4308Q35960987-B71A4FAC-5510-4E95-9B2C-F60B259F5AF5Q36076037-DBB3B629-C458-486D-AA74-954484F9B756Q36174022-E027FA7D-77C4-49B2-8B25-05D48B9AE0DEQ36396241-5320BF15-A142-48C1-874D-24A41C759FACQ37074826-1A712B8B-240B-42DE-9EDE-CF588BAA33B8Q38124261-C0050CD1-1B9B-4B47-9909-B9D28AD21345Q38144839-D74C67AA-C5C7-4975-9CE9-BAA5E2F579A6Q38494436-8618E4D6-5F8D-47EC-B99F-5078CDE8C511Q38718396-636AB0B4-03C3-41DA-A201-87334D5C55D6Q38739933-65647952-7DCF-4A26-A46A-E2A2108CA911Q38977310-3CFAE1AF-6272-4500-A8C6-5E1A3D5FF94AQ41094161-502DB7FF-9BC2-4D22-B6D3-F11D0C76BCA5Q41701192-8318659A-230E-4789-AB71-4B3C2A7572B2Q41729454-8F0C368B-530D-4702-AAC0-89D42C851ED1Q42618592-59053B7F-E036-49BC-9A0C-D1D3ACF91C1CQ42714470-DA08DEAA-FD0B-4F9A-B91D-29FE2FFF74A8Q45223094-3AF445EA-0418-47AE-96ED-902BA9CA8328Q49174862-4D23D4FD-A3BA-45E0-8048-5D9AA59E2F29Q55333929-4C095B80-2351-44F6-9B7C-12FE96D824B7Q56828266-454B58AD-871C-4DEC-BAEA-59B2CE9687D6Q57222227-17CDF09A-FE77-47E4-9A06-4BF8E0C561D3
P2860
Systematic analysis of pyrazinamide-resistant spontaneous mutants and clinical isolates of Mycobacterium tuberculosis.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Systematic analysis of pyrazin ...... of Mycobacterium tuberculosis.
@ast
Systematic analysis of pyrazin ...... of Mycobacterium tuberculosis.
@en
type
label
Systematic analysis of pyrazin ...... of Mycobacterium tuberculosis.
@ast
Systematic analysis of pyrazin ...... of Mycobacterium tuberculosis.
@en
prefLabel
Systematic analysis of pyrazin ...... of Mycobacterium tuberculosis.
@ast
Systematic analysis of pyrazin ...... of Mycobacterium tuberculosis.
@en
P2093
P2860
P356
P1476
Systematic analysis of pyrazin ...... of Mycobacterium tuberculosis.
@en
P2093
Karolien Stoffels
Maryse Fauville-Dufaux
René Wintjens
Vanessa Mathys
P2860
P304
P356
10.1128/AAC.05385-11
P407
P50
P577
2012-07-23T00:00:00Z